Cellectar Biosciences (CLRB)

• Market cap: $13.8M
• 1 day: -7.41%
• 5 days: 0.62%
• 1 month: -8.19%
• 3 months: -9.47%
• 6 months: -32.57%
• Year to date: -6.34%
• 1 year: -62.34%
• 5 years: -99.43%
• 10 years: -99.98%
• Sector: Healthcare
• Industry: Biotechnology

About: Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Employees: 11